Last Post: 09/15/2020 7:46:28 AM
Board Marks: 0
Posts Today: 0
Board Views Today: 1
XORTX Therapeutics Inc. is a biopharmaceutical company with three clinically advanced products in development, XRx-008 for Autosomal Dominant Polycystic Kidney Disease (ADPKD), XRx-101 for Coronavirus / COVID-19 infection and XRx-221, under a letter of intent to establish a co-development program with Teijin Pharma Limited, for Type 2 Diabetic Nephropathy (T2DN). The Company has strong intellectual property rights and established proof of concept through independent clinical studies. XORTX is working to advance its clinical development stage products that target xanthine oxidase to inhibit production of uric acid. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future of patients. Additional information on XORTX Therapeutics is available at www.xortx.com.
XORTX Therapeutics Inc. (XRTXF) Research Links
XORTX Therapeutics Inc. (OTCMRKTS: XRTXF) Stock Message Board
Post
Subject
Author
Posted On
| 31915 | Sponsor | 09/25/2020 11:42:09 AM | |
| 8 | $XRTXF XORTX Highlights New Studies of Acute | hotforpenny | 09/15/2020 7:46:28 AM |
| 7 | XRX CSE $XRTXF OTCQB Latest updates & | hotforpenny | 09/08/2020 2:33:58 PM |
| 6 | $XRTXF XORTX Files U.S. FDA Pre-IND Meeting | hotforpenny | 08/31/2020 8:56:52 AM |
| 5 | $XRTXF XORTX Therapeutics Moves Toward Phase 3 | hotforpenny | 08/19/2020 11:55:21 AM |
| 4 | $XRTXF $XRX Recently Partners with Mount | hotforpenny | 08/07/2020 8:52:56 AM |
| 3 | $XRTXF XORTX Partners with Mount Sinais Icahn | hotforpenny | 08/04/2020 11:24:09 AM |
| 2 | $XRTXF DD. | hotforpenny | 06/25/2020 10:13:24 AM |
| 1 | $XRTXF 6/23 News! Announces Mr. Anthony J. | hotforpenny | 06/25/2020 10:08:43 AM |
